Thursday, 29 February, 2024
HomeHaematologyAntibiotic reduces mortality in haemodialysis patients

Antibiotic reduces mortality in haemodialysis patients

An antibiotic therapy known to reduce catheter-related bloodstream infections in haemodialysis patients has been shown for the first time to reduce mortality. [s]Medical Xpress[/s] reports that a [b]Henry Ford Health System[/b] study found that a low-dose ‘lock’ solution of gentamicin/citrate reduced mortality by 68% compared to a solution of heparin, a blood-clotting therapy long considered the standard of care. Additionally, the gentamicin/citrate solution was associated with a 73% reduction in bloodstream infections compared to the heparin treatment. Bloodstream infections are a leading cause of hospitalisation and death in haemodialysis patients. Dr Jerry Yee ,of Henry Ford, says the findings suggest the antibiotic therapy is a potential game-changer for haemodialysis treatment.

[link url=]Full Medical Xpress report[/link]
[link url=]Clinical Journal of the American Society of Nephrology abstract[/link]

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.